RxDoctor Payments Data

Lauren Fanion, NP

Psychiatric/Mental Health · Port Huron, MINPI 1538790373

Payments from drug & device makers

$1,524in general payments, 2019–2025

Across 93 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$351
  • Neurocrine Biosciences, Inc.$276
  • E.r. Squibb & Sons, L.L.C.$185
  • Indivior Inc.$160
  • Johnson & Johnson$145
  • Teva Pharmaceuticals USA, Inc.$131
  • plus $275 from 7 others

What the payments were for

  • Food & beverage$1,51599%
  • Education$91%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,524 in reported general payments places this provider in the 70th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$10,411
Medicare patients
62
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$110,155
Abilify MaintenaAripiprazole20$49,848
Invega SustennaPaliperidone Palmitate15$46,688
LybalviOlanzapine/Samidorphan Malate16$26,082
RexultiBrexpiprazole11$25,728
VyvanseLisdexamfetamine Dimesylate15$5,709
TrintellixVortioxetine Hydrobromide11$3,657
Duloxetine Hcl20$1,462
Lamotrigine ErLamotrigine15$1,287
Divalproex Sodium ErDivalproex Sodium23$1,086
Clozapine25$884
Paliperidone ErPaliperidone11$747
Quetiapine Fumarate34$688
Venlafaxine Hcl ErVenlafaxine Hcl30$658
Trazodone Hcl79$555

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$276$110,15513 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$102$75,57731 claims
Johnson & JohnsonInvega Sustenna$145$46,68815 claims
Alkermes, Inc.Lybalvi$351$26,08216 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix$15$9,36726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →